Reports

Current Reports (translated reports do not inlcude technical ones)

April 29 2022

Current Report No 6

Signing a commercial agreement to sell Genomtec® ID
February 14 2022

Current Report No 3

Commencement of comparative research
January 20 2022

Current Report No 2

Receipt of the decision on granting patent protection from the European Patent Office
January 12 2022

Current Report No 1

Start of pilot production of analysers Genomtec®ID in the UK
December 24 2021

Current Report No 31

Acceleration of the Genomtec® ID platform commercialization and signing up loan agreements in connection to financing of the fast-tracked project activities
November 29 2021

Current Report No 30

Patent filing application for a method of heat transfer and its measurement with the UK Intellectual Property Office (UK IPO)
November 19 2021

Current Report No 29

Receipt of the decision on granting patent protection for the proprietary set of primers, diagnostic method, and the use of primer set for HPV infection detection to genetically diagnose HPV16 (Human papillomavirus type 16) in the territory of Republic of Poland
November 3 2021

Current Report No 27

Planned acceleration of the Genomtec®ID platform commercialization process
October 29 2021

Current Report No 26

Submission to the Financial Supervision Authority of an application for approval of the prospectus of Genomtec S.A.
October 28 2021

Current Report No 25

Receipt of the decision on granting patent protection for the temperature control invention in the territory of Republic of Poland
September 21 2021

Current Report No 23

Receipt of the decision on granting patent protection for the invention in the territory of Japan
August 25 2021

Current Report No 21

Patent application filed for the proprietary set of primers, diagnostic method, and the reaction mixture composition to genetically diagnose Salmonella enterica infections in LAMP technique
August 6 2021

Current Report No 18

TÜV Rheinland has issued ISO 13485 certificate for Genomtec
July 7 2021

Current Report No 16

Patent filing application for the proprietary set of primers, diagnostic method and the reaction mixture composition to genetically diagnose Neisseria Meningitidis in LAMP technique
June 23 2021

Current Report No 13

A contract signed with specialist clinical center based in Gliwice to execute part of the comparative study (referenced to the Real-Time RT-PCR method) validating the SARS-CoV-2 infection detection kit based on the saliva Direct-RT-LAMP technology
May 25 2021

Current Report No 11

A contract signed with Cellgen Molecular Pathology Centre, Aurimed Private Healthcare Trust to execute part of the comparative study (referenced to the Real-Time RT-PCR method) validating the SARS-CoV-2 infection detection kit based on the saliva Direct-RT-LAMP technology
May 17 2021

Current Report No 10

Market authorisation for sales of Genomtec® SARS-CoV-2 EvaGreen® Direct-RT-LAMP CE-IVD Kit
May 10 2021

Current Report No 9

Patent protection has been granted for a set of primers for amplifying the nucleotide sequence of Borrelia burgdorferi, a method for detecting Borrelia burgdorferi, a method for diagnosing Lyme disease and a kit for diagnosing Lyme disease
June 30 2021

Current Report No 8

Signatory of a cooperation agreement leading to opening of a diagnostic laboratory that utilizes Issuer’s products and know-how
April 22 2021

Current Report No 6

Patent filing application for the proprietary set of primers, diagnostic method and the reaction mixture composition to genetically diagnose MRSA (methicillin-resistant staphylococcus aureus) in LAMP technique